We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Barclays Continues to Face Revenue and Brexit Challenges
Read MoreHide Full Article
Shares of Barclays (BCS - Free Report) have lost 16.9% over the past three months compared with 8.9% fall of the industry it belongs to. Though the company’s restructuring and streamlining efforts have been successful in lowering operating expenses, revenue growth remains muted owing to low interest rates.
Moreover, uncertainty related to Brexit and litigation matters remain other near-term concerns for the company.
Barclays’ revenues have been under pressure for the past few years. The company’s core operating performance indicators like net interest income, net fee and commission income, and net trading income have not displayed any significant improvement due to dismal capital markets performance as well as low interest rate environment.
Further, the Brexit-related ambiguity is expected to hurt its growth prospects in the near term. Barclays’ bottom-line growth is also likely to be adversely impacted by the litigation issues, which the company continues to face.
Though the company has been successful in resolving certain issues over the past few years, some regulatory and legal restrictions still remain headwinds. These are expected to limit its flexibility in the near future.
Thus, given the concerns, analysts are bearish on the stock. Over the past 30 days, the Zacks Consensus Estimate for earnings has been revised 5.2% and 3.8% downward for 2018 and 2019, respectively. As a result, the stock currently carries a Zacks Rank #4 (Sell).
The Zacks Consensus Estimate for AllianceBernstein has moved 2.4% upward for 2018, in the last 60 days. Its share price has increased 22.3% in the past 12 months.
Lazard’s Zacks Consensus Estimate has been revised 2.5% upward for 2018, in the last 60 days. The company’s share price has increased 14.3% in the past 12 months.
The Zacks Consensus Estimate for Regional Management has been revised 1.3% upward for 2018, in the last 60 days. Its share price has jumped49.1% in the past year.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Barclays Continues to Face Revenue and Brexit Challenges
Shares of Barclays (BCS - Free Report) have lost 16.9% over the past three months compared with 8.9% fall of the industry it belongs to. Though the company’s restructuring and streamlining efforts have been successful in lowering operating expenses, revenue growth remains muted owing to low interest rates.
Moreover, uncertainty related to Brexit and litigation matters remain other near-term concerns for the company.
Barclays’ revenues have been under pressure for the past few years. The company’s core operating performance indicators like net interest income, net fee and commission income, and net trading income have not displayed any significant improvement due to dismal capital markets performance as well as low interest rate environment.
Further, the Brexit-related ambiguity is expected to hurt its growth prospects in the near term. Barclays’ bottom-line growth is also likely to be adversely impacted by the litigation issues, which the company continues to face.
Though the company has been successful in resolving certain issues over the past few years, some regulatory and legal restrictions still remain headwinds. These are expected to limit its flexibility in the near future.
Thus, given the concerns, analysts are bearish on the stock. Over the past 30 days, the Zacks Consensus Estimate for earnings has been revised 5.2% and 3.8% downward for 2018 and 2019, respectively. As a result, the stock currently carries a Zacks Rank #4 (Sell).
Stocks Worth Considering
A few better-ranked stocks in the finance space are AllianceBernstein Holding L.P. (AB - Free Report) , Lazard Ltd (LAZ - Free Report) and Regional Management Corp. (RM - Free Report) . All these stocks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for AllianceBernstein has moved 2.4% upward for 2018, in the last 60 days. Its share price has increased 22.3% in the past 12 months.
Lazard’s Zacks Consensus Estimate has been revised 2.5% upward for 2018, in the last 60 days. The company’s share price has increased 14.3% in the past 12 months.
The Zacks Consensus Estimate for Regional Management has been revised 1.3% upward for 2018, in the last 60 days. Its share price has jumped49.1% in the past year.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>